Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
Karyopharm Therapeutics Awards 2022
Karyopharm Therapeutics won 1 award in 2022 and 4 awards in 2021. In 2022, Karyopharm Therapeutics won for Best Company Compensation. In 2021, Karyopharm Therapeutics won for Best Company Culture 2021, Best Places to Work in Boston 2021, Best Leadership Teams 2021 and Best Company Compensation. Based on 2,628 ratings and 90 participants, employees at Karyopharm Therapeutics are very satisfied with their work experience. The overall culture score, 79/100 or A-, incorporates employee ratings based on their feedback on the Compensation, Team, Executive Team and more.
Comparably Awards are provided yearly to top performing company cultures based on real feedback from their employees.
Best Company Compensation 2022 (Small & Midsize Companies)Karyopharm TherapeuticsBest Company Compensation
Help Your Company Win 2025 Awards
Anonymously rate your experience & help make Karyopharm Therapeutics a better place to work.
Awards Press for Karyopharm Therapeutics
×